Invesco’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Sell |
99,703
-1,229,251
| -92% | -$17.2M | ﹤0.01% | 2720 |
|
|
2025
Q1 | $20.8M | Buy |
1,328,954
+202,286
| +18% | +$3.16M | ﹤0.01% | 1420 |
|
|
2024
Q4 | $15.7M | Buy |
1,126,668
+188,184
| +20% | +$2.62M | ﹤0.01% | 1605 |
|
|
2024
Q3 | $8.73M | Buy |
938,484
+890
| +0.1% | +$8.28K | ﹤0.01% | 1907 |
|
|
2024
Q2 | $8.72M | Buy |
937,594
+65,250
| +7% | +$607K | ﹤0.01% | 1869 |
|
|
2024
Q1 | $8.64M | Buy |
872,344
+847,208
| +3,370% | +$8.4M | ﹤0.01% | 1902 |
|
|
2023
Q4 | $81.2K | Buy |
25,136
+63
| +0.3% | +$203 | ﹤0.01% | 3698 |
|
|
2023
Q3 | $133K | Sell |
25,073
-246
| -1% | -$1.31K | ﹤0.01% | 3666 |
|
|
2023
Q2 | $241K | Buy |
25,319
+1,289
| +5% | +$12.3K | ﹤0.01% | 3550 |
|
|
2023
Q1 | $264K | Buy |
24,030
+7,195
| +43% | +$79.1K | ﹤0.01% | 3523 |
|
|
2022
Q4 | $249K | Sell |
16,835
-1,786
| -10% | -$26.4K | ﹤0.01% | 3574 |
|
|
2022
Q3 | $356K | Sell |
18,621
-190,554
| -91% | -$3.64M | ﹤0.01% | 3415 |
|
|
2022
Q2 | $4.46M | Buy |
209,175
+197,916
| +1,758% | +$4.22M | ﹤0.01% | 2341 |
|
|
2022
Q1 | $217K | Buy |
11,259
+199
| +2% | +$3.84K | ﹤0.01% | 3720 |
|
|
2021
Q4 | $229K | Sell |
11,060
-2,054
| -16% | -$42.5K | ﹤0.01% | 3691 |
|
|
2021
Q3 | $314K | Buy |
13,114
+1,029
| +9% | +$24.6K | ﹤0.01% | 3604 |
|
|
2021
Q2 | $331K | Buy |
+12,085
| New | +$331K | ﹤0.01% | 3562 |
|